Genes2Me
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Genes2Me is a biotechnology, genetics, and health care company that develops and manufactures in-vitro diagnostic (IVD) solutions, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, and RT-PCR kits.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genes2Me Comparables
Compare Genes2Me with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mylab Discovery Solutions | 86% | |
| NeoDx Biotech Labs | 81% | |
| GenePath Diagnostics | 80% | |
Genes2Me Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Open roles increased to 27, representing 24% of headcount.
- May 17, 2026
Monthly visitors increased 44% MoM, from 3.9K to 5.7K.
Genes2Me Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genes2Me's valuation, stock price, and market status.